Orthometrix, Inc. (OMRX) Comparison with companies in other sectors?

Orthometrix, Inc. has a share price of 53.21M. You can analyze Orthometrix, Inc. (OMRX) competitors across different market sectors through stock heatmaps.

What are OMRX's NET and operating margins?

Orthometrix, Inc. (OMRX) operating margin is around 0.17, and net profit margin is approximately 0.27 as of the latest reports.

In what way does OMRX's earnings per share (EPS) trend reflect its financial momentum?

Orthometrix, Inc. (OMRX) EPS is -0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Orthometrix, Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Orthometrix, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Orthometrix, Inc. like P/E which is 0.01, P/B which is -0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Orthometrix, Inc.

OMRX•PNK

Healthcare

Medical - Specialties

$0.00

$0.00(0.00%)

Fundamental Analysis of Orthometrix, Inc. (OMRX)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.02

P/E Ratio

ROE

-0.15%

Net Margin

0.27%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.32K

Shares OutstandingTotal number of shares issued

$53.21M

Book Value/ShareNet worth per share

$-0.05

Revenue/ShareAnnual revenue per share

$0.03

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.02

Net MarginNet income as percentage of revenue

27.20%

Operating MarginOperating income as percentage of revenue

17.22%

ROEReturn on shareholders' equity

-15.23%

ROAReturn on total assets

51.39%

ROCEReturn on capital employed

39.97%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.006

Cash/ShareCash and equivalents per share

$0.004

FCF YieldFree cash flow as percentage of market cap

6162.56%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for OMRXFinancial Ratios Analysis details for OMRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for OMRXSector Benchmarking details for OMRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Orthometrix, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Orthometrix, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Orthometrix, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Orthometrix, Inc.

For Orthometrix, Inc., essential financial indicators include EPS -0.02, PE -, and ROE -0.15. These key ratios reveal insights into Orthometrix, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Orthometrix, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Orthometrix, Inc.

Metrics like Net Margin 27.20% and ROA 51.39% shed light on how well Orthometrix, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Orthometrix, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Orthometrix, Inc.

Using ratios such as P/B Ratio -0.00 and PEG Ratio 0.00, investors can assess whether Orthometrix, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Orthometrix, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Orthometrix, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.22 and Cash Flow $0.006, provide a snapshot of Orthometrix, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Orthometrix, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Orthometrix, Inc.

Investing in Orthometrix, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Orthometrix, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;